FREE
SHIPPING!

on all orders above $300.00

FREE Pills!

via4gra pills

for free with every order

OUR DRUG PRICES are

70%

Less than in your
local pharmacy

Search by letter:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Sinemet (Carbidopa Levodopa)
+ BONUS

Rating of sales:          

 
Sinemet

Generic Sinemet is a high-quality medication which is used to treat symptoms of Parkinson's disease. Generic Sinemet can also be used to treat Parkinson-like symptoms caused by manganese poisoning, encephalitis, carbon monoxide poisoning. Levodopa is central nervous system agent. Carbidopa is decarboxylase inhibitor. Levodopa gives anti-Parkinson's effect and carbidopa work by protecting levodopa effectiveness.

Other names for this medication:

Similar Products:
Parlodel, Neupro, Pramipexole, Ropinirole, Requip

 

Also known as:  Carbidopa Levodopa.

Description

Generic Sinemet is a perfect remedy which is used to treat symptoms of Parkinson's disease caused by manganese poisoning, encephalitis, carbon monoxide poisoning. Levodopa is central nervous system agent. Carbidopa is decarboxylase inhibitor. Levodopa gives anti-Parkinson's effect and carbidopa work by protecting levodopa effectiveness.

Generic name of Generic Sinemet is Levodopa and Carbidopa.

Sinemet is also known as Carbidopa-Levodopa, Parcopa, Syndopa.

Brand names of Generic Sinemet are Sinemet, Parcopa, Sinemet CR, Stalevo.

Dosage

Generic Sinemet is available in tablets (10mg + 100mg, 25mg + 100mg, 25mg + 250mg), orally disintegrating tablets, extended-release tablets orally.

Usually tablets and disintegrating tablets are taken 3-4 times a day. The extended-release tablets are usually taken 2-4 times a day. Take Generic Sinemet before meal with water.

Do not take Generic Sinemet if you are under 18.

Do not crush or chew it.

If you want to achieve most effective results do not stop taking Generic Sinemet suddenly.

Overdose

If you overdose Generic Sinemet and you don't feel good you should visit your doctor or health care provider immediately. Symptoms of Generic Sinemet overdosage: muscle twitches, inability to open the eyes.

Storage

Store at room temperature between 15 and 30 degrees C (59 and 86 degrees F) away from moisture, light and heat. Throw away any unused medicine after the expiration date. Keep out of the reach of children.

Side effects

The most common side effects associated with Sinemet are:

  • sinemet generic name
  • sinemet max dose
  • sinemet maximum dosage
  • sinemet drug
  • sinemet 500 mg
  • sinemet usual dosage
  • sinemet cr dosage
  • sinemet dosage frequency
  • sinemet renal dosing
  • sinemet 100 mg
  • sinemet dosage intervals
  • sinemet brand name
  • sinemet 10 mg
  • sinemet overdose symptoms
  • sinemet starting dose
  • sinemet maximum dose
  • sinemet with alcohol
  • sinemet buy online
  • sinemet 50 mg
  • sinemet dosing question
  • sinemet normal dosage
  • sinemet dosage forms
  • sinemet drug classification
  • sinemet 30 tablet
  • sinemet drug information
  • sinemet online
  • sinemet dosage
  • sinemet cost
  • sinemet storage temperature
  • sinemet missed dose
  • sinemet dosing frequency
  • sinemet highest dose
  • sinemet gel
  • sinemet plus dosage
  • sinemet drug class
  • sinemet drug company
  • sinemet oral suspension
  • sinemet 75 mg
  • sinemet medication dosages
  • sinemet cr dosing
  • sinemet user reviews
  • sinemet starting dosage
  • sinemet drug components
  • sinemet dosing interval
  • sinemet and alcohol
  • sinemet generic cost
  • sinemet vs generic
  • sinemet 200 mg
  • sinemet drug card
  • sinemet dosing schedule
  • sinemet pill pictures
  • sinemet overdose
  • sinemet y alcohol
  • sinemet medication
  • sinemet cr generic
  • sinemet tablets
  • sinemet dosing
  • sinemet drug interactions
  • sinemet yellow pill
  • sinemet generic
  • sinemet 1000 mg
  • sinemet generic equivalent
  • sinemet medicine
  • sinemet dosage interval
  • sinemet reviews
  • sinemet drug uses
  • sinemet dosage schedule

Side effect occurrence does not only depend on medication you are taking, but also on your overall health and other factors.

Contraindications

Do not take Generic Sinemet if you are allergic to Generic Sinemet components.

Do not take Generic Sinemet if you are pregnant, planning to become pregnant or breast-feeding.

Be careful using Generic Sinemet if you take iron pills and vitamins containing iron; metoclopramide (such as Reglan); isoniazid (such as Nydrazid, INH); isocarboxazid (such as Marplan); phenytoin (such as Dilantin); antihistamines; risperidone (such as Risperdal); antidepressants (protriptyline (such as Vivactil), clomipramine (such as Anafranil), doxepin (such as Sinequan, Adapin), amitriptyline (such as Elavil), desipramine (such as Norpramin), trimipramine (such as Surmontil), amoxapine (such as Asendin), nortriptyline (such as Pamelor, Aventyl), imipramine (such as Tofranil); selegiline (such as Eldepryl); ipratropium (such as Atrovent); rasagiline (such as Azilect); haloperidol (such as Haldol); high blood pressure medicines; motion sickness, ulcers, irritable bowel disease, nausea, urinary problems, mental illness medications; papaverine (such as Pavabid), tranyllcypromine (such as Parnate) or phenelzine (such as Nardil).

It can be dangerous to use Generic Sinemet if you suffer from or have a history of glaucoma, undiagnosed mole, melanoma, suspicious, phenylketonuria, mental illness; diabetes; heart attacks; asthma; bronchial asthma; endocrine disorder; emphysema; ulcers; active peptic ulcer; hormone problems; irregular heartbeat; kidney, liver, blood vessel, lung or heart disease.

Be careful with Generic Sinemet if you are going to have a surgery.

Do not take Generic Sinemet if you are under 18.

Avoid driving machine.

It can be dangerous to stop Generic Sinemet taking suddenly.

sinemet dosage forms

The multiple-dose (200 mg levodopa t.i.d.) pharmacokinetic profile of two controlled-release products of levodopa (Madopar HBS and Sinemet CR) was compared to conventional Madopar capsules in 18 healthy volunteers in a cross-over, randomized design. A pronounced controlled-release profile of the Madopar HBS and Sinemet CR product was demonstrated compared to conventional Madopar capsules with a significant (p < 0.001) decrease (-40 and -55%) in Cmax and a significant (p < 0.001) increase (+237 and +256%) in morning Cmin for the 200 mg t.i.d. dosage schedule. Almost equivalent bioavailability (85-90%) of levodopa was demonstrated for the controlled-release formulations relative to that of conventional Madopar capsules. The Madopar HBS formulation was bioequivalent with Sinemet CR with respect to levodopa, but it exhibited a moderately higher fluctuation index compared to Sinemet CR as a result of somewhat higher Cmax and lower Cmin values for the Madopar HBS formulation. 3-OMD (a metabolite of levodopa) levels were significantly (p < 0.05) higher for Madopar HBS and Madopar compared to Sinemet CR. The higher 3-OMD levels for the levodopa/benserazide combinations are consistent with a more potent decarboxylase inhibitory activity of benserazide as compared to carbidopa. The number of adverse events was highest for conventional Madopar (n = 18) compared to the controlled-release formulations (n = 12 for Sinemet CR and only 2 for Madopar HBS). A more efficient inhibition of dopamine formation from levodopa (resulting in higher 3-OMD levels) by Madopar HBS was consistent with the superior tolerability (especially for initial nausea) observed for the Madopar HBS formulation as compared to Sinemet CR.

sinemet drug class

PD was induced by administration of reserpine (5 mg/kg/day, i.p for 5 consecutive days), haloperidol (1 mg/kg, i.p.), and tacrine (2.5 mg/kg, i.p.) in experimental animals. The symptoms of PD such as tremors, akinesia, rigidity, catalepsy, and vacuous chewing movements (VCMs) were evaluated. Foot shock-induced aggression (FSIA) model was used to confirm anti-parkinsonian activity. The methanolic extract of Beta vulgaris (MEBV) was administered at doses of 100, 200, and 300 mg/kg, p.o. The combination of L-dopa and carbidopa was used as a standard drug. Behavioral studies such as locomotor activity and grip strength were determined, and oxidative stress was evaluated in FSIA model in rat brain.

sinemet online

Continuous duodenal levodopa infusion (DLI) is an effective therapy that improves quality of life (QoL) in advanced Parkinson's disease (PD). However, the impact of DLI on caregivers' stress and burden has not been reported.

sinemet usual dosage

A primate model of Parkinson's disease was obtained by i. v. administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). A behavioural, a mechanographic and an electromyographic (EMG) study were carried out during the execution of a rapid elbow movement, in two normal monkeys and, after the MPTP administration, before and after a L-DOPA therapy. Disturbances in behavior, movement parameters and EMG activity observed in MPTP-treated monkeys mimic those reported in Parkinsonian patients. Treatment with L-DOPA was effective in greatly correcting these disturbances. These results lend weight to the assumption that use of MPTP in primate provides a good model to study Parkinson's disease.

sinemet drug

Serum prolactin (PRL) level was assessed after challenges with apomorphine hydrochloride, saline, dopamine hydrochloride, or levodopa-carbidopa (Sinemet) in 19 control and 38 chronic schizophrenic subjects. Baseline PRL level varied inversely with age. High correlations existed between baseline PRL level and any subsequent absolute measure of PRL after administration of a dopamine agonist or placebo. Percent decrease was not a function of baseline concentrations and was therefore the only independent measure of drug response. Baseline PRL level was generally lower during exacerbation than remission in patients studied during two states of illness. Percent PRL level decrease after apomorphine administration was significantly greater in normal subjects than in schizophrenics. Correction of apomorphine responses for corresponding placebo (saline) values abolished differences between groups. Prolactin responses after dopamine or levodopa-carbidopa did not differ; however, placebo correction was not possible.

sinemet 50 mg

Burning mouth syndrome has been reported as being more common in Parkinson's disease patients than the general population. While the pathophysiology is unclear, decreased dopamine levels and dopamine dysregulation are hypothesized to play a role. We report a patient with Parkinson's disease who developed burning mouth syndrome with carbidopa/levodopa. Our patient had resolution of burning mouth symptoms when carbidopa/levodopa was replaced with a dopamine agonist. Based on our patient's clinical course, in conjunction with earlier studies assessing the relationship between burning mouth syndrome and Parkinson's disease, we discuss a potential role for dopamine in burning mouth syndrome in Parkinson's disease.

sinemet 30 tablet

Therapeutic responses to Sinemet CR were studied in 37 patients with early Parkinson's disease previously treated with standard (Madopar) or controlled-release (Madopar HBS) levodopa/benserazide combinations. Patients were followed up for a 3-month period. The optimal therapeutic response of parkinsonian disability to Sinemet CR was equal to that obtained with Madopar or Madopar HBS. The optimal therapeutic dosage of Sinemet CR was equal to that of Madopar HBS but 12% higher than that of standard Madopar. However, with Sinemet CR treatment, the number of daily doses needed was significantly fewer than with both previous treatments. End-of-dose failure, which had developed in 4 patients, and peak-dose dyskinesias present in 6 patients during treatment with standard Madopar, improved significantly with Sinemet CR. Thus, Sinemet CR seems to be beneficial and useful in the treatment of early Parkinson's disease.

sinemet drug components

Some investigators have proposed that Parkinson's disease (PD) patients often exhibit a worsening of tremor before the emergence of levodopa-induced dyskinesia (LDD). It is not clear, however, whether the presence of tremor depends on the severity of dyskinesia, nor is the precise time course of tremor relative to dyskinesia well understood. This report describes an objective study of the relationship between postural tremor and dyskinesia in eight PD patients who showed signs of choreoathetoid hand movements after a single dose of levodopa. Spectral analysis of sustained hand force provided an objective and sensitive method of detecting worsening of tremor in patients with LDD. Severity of clinical symptoms was highly correlated with severity of dyskinesia. Six of the patients exhibited increased tremor amplitude within 45 min of exposure to levodopa, with two of the six patients experiencing bilateral and four of the six having unilateral worsening of postural tremor. Tremor was more severe on the side with the more severe dyskinesia. These findings provide objective support for the notion that dyskinesia and postural tremor may stem from a common pathophysiologic mechanism.

Target Point Shipping Method Tracking Delivery Time Price
Worldwide shipping

Worldwide shipping

Registered Mail  Not trackable 14-21 business days USD 20.00 per order
EMS  Trackable, where available 5-9 business days USD 30.00 per order

Delivery time is:

Registered Mail - 14-21 business days, prices - USD 20.00, no signature is required on delivery.
EMS - 5-9 business days, prices - USD 30.00, signature is required on delivery.
Your order will be packed safe and secure and dispatched within 24 hours.

front back side

This is exactly how your parcel will look like (pictures of a real shipping item). It has a look of a regular private letter and does not disclose its contents. Size - 9.4x4.3x0.3 inches (24x11x0.7cm).

Testimonials
Best
 Show Hide 
sinemet with alcohol 2016-09-16

Both procedures showed a significant improvement in UPDRS-II, UPDRS-III, and UPDRS-IV and a considerable reduction in the percentage of waking day spent in "off," whereas only the STN-DBS group showed a significant improvement in dyskinesias duration and disability. STN-DBS was associated to a significant drop in the phonemic verbal fluency score, whereas Duodopa patients showed a milder worsening in this task. The buy sinemet procedure-related complications occurred more frequently with Duodopa.

sinemet drug information 2015-04-28

Levodopa/carbidopa is buy sinemet the most effective medical therapy for Parkinson's disease, but it's associated with dyskinesia.

sinemet 1000 mg 2017-04-29

Thirteen older amblyopic children were randomly assigned to receive or not receive part-time occlusion (3 h/day) combined with 7 weeks of oral dosing with levodopa-carbidopa (1.02 mg/0.25 mg/kg body weight three times daily). Visual acuity, contrast sensitivity, and fusion were measured at baseline; 1, 3, 5, and 7 weeks during the treatment regimen; and 4 weeks after termination Aciphex Generic Alternative of all treatment. At these same times health status was assessed with standard laboratory blood tests, physical examination, and subjective questionnaire.

sinemet dosing schedule 2015-01-18

Mood swings accompanying the motor fluctuations of patients with Parkinson's disease on chronic levodopa treatment frequently occur, but are poorly recognized. Occasionally, their functional impact may be greater than that caused by the motor disability itself. In this study we have assessed the nature of, and relationship between, mood and motor fluctuations in nine Parkinsonian patients with 'on-off' motor swings. The results of an additional questionnaire survey confirm that 'on-off' mood swings occur in approximately two thirds of patients with Parkinson's disease experiencing motor fluctuations Cymbalta Neuropathy Reviews on dopaminergic treatment. Aetiological and therapeutic implications are discussed.

sinemet 200 mg 2016-11-10

Acute doses of Sinemet® (L-DOPA combined with carbidopa) previously failed to influence prolonged exercise performance in a temperate environment, but it is not known whether acute doses of L-DOPA timed to reach maximum plasma concentrations (Cmax) during exercise will improve prolonged cycling performance in warm conditions (30.2 Aggrenox Drug Cost °C ± 0.2°C, 50% ± 1%).

sinemet 500 mg 2017-01-26

An open cross-over study of 20 patients with Parkinson's disease performed with two drugs containing L-dopa and a peripheral aromatic amino acid decarboxylase inhibitor (benserazide, carbidopa) confirmed the conclusions reached in other clinical trials that this combined treatment of Parkinson's disease is the most effective form of drug therapy available at present. With both drugs, Madopar or Sinemet Stromectol 3 Mg , an optimum therapeutic result was obtained with relatively small doses of L-dopa (the reduction in L-dopa dosage amounting to about 80%). A loss of efficacy with both drugs, which has observed during long-term treatment of patients with Parkinson's disease, could be avoided by switching the patients from Sinemet to Madopar and vice versa. Determination of L-dopa in the plasma demonstrated that with either drug similar plasma levels of L-dopa were achieved during clinically effective treatment.